CN101679496A - 用于由vwf前肽制备成熟vwf的方法 - Google Patents
用于由vwf前肽制备成熟vwf的方法 Download PDFInfo
- Publication number
- CN101679496A CN101679496A CN200880016374A CN200880016374A CN101679496A CN 101679496 A CN101679496 A CN 101679496A CN 200880016374 A CN200880016374 A CN 200880016374A CN 200880016374 A CN200880016374 A CN 200880016374A CN 101679496 A CN101679496 A CN 101679496A
- Authority
- CN
- China
- Prior art keywords
- vwf
- propetide
- furin
- ripe
- exchange resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
步骤 | 缓冲液 | 缓冲液体积 | 流速 | 时间 | 注解 |
CV | cm/h | ||||
前置条件 | SIP1,WP2,EP/WP1 | 15 | 150 | 36分钟 | |
加载 | 经1∶4.5稀释的初始材料(在室温下<15mS/cm) | 约765 | 150 | 约26小时 | 160-180VWF Ag U/ml树脂 |
洗涤1 | EP/WP | 5 | 150 | 12分钟 | |
洗涤2 | FE1 | 5 | 150 | 12分钟 | 50mM HEPES,150mM NaCl,1mM CaCl2,pH=7.0(室温) |
Furin活化 | 用缓冲液FE1稀释的Furin(约15mS/cm) | 2-4 | 低 | 8小时 | 用缓冲液FE1∶50mM HEPES、150mM NaCl,1mM CaCl2,pH=7.0(室温)稀释,体积循环约4-5次 |
洗涤3 | FE1 | 1 | 150 | 2.4分钟 | |
洗涤4 | EP/WP | 5 | 150 | 12分钟 | |
洗脱,变量1 | EP1 | 20 | 75 | 96分钟 | |
洗脱,变量2 | 梯度:20%EP3/80%EP4至80%EP3/20%EP4 | 7 | 75 | 33分钟 | |
洗脱,变量2 | EP3 | 10 | 150 | 24分钟 | |
后置条件 | WP2,SIP1,WP2,EP/WP2 | 20 | 150 | 48 | T(温度)=约30℃ |
TMC | 加载VWFAg | 活性Furin/VWF | 熟化时间 | 熟化温度 | 洗脱液池中的VWF前肽含量 | 装载物中的VWF前肽含量 |
U/ml树脂 | U/U | 小时 | ℃ | %VWF Ag | %VWF Ag | |
ORVWTMC06006 | 124 | 0.7 | 4 | 20 | 0.64 | 49.61 |
ORVWTMC06007 | 133 | 1.3 | 4 | 20 | 0.64 | 61.64 |
ORVWTMC06008 | 113 | 0.7 | 4 | 20 | 0.52 | 58.62 |
ORVWTMC06009 | 120 | 0.7 | 4 | 20 | 0.71 | 65.58 |
ORVWTMC06010 | 144 | 2.0 | 4 | 20 | 0.64 | 55.34 |
ORVWTMC06011 | 159 | 0.4 | 4 | 20 | 2.61 | 42.46 |
ORVWTMC06012* | 123 | 0.1 | 4 | 20 | 8.15 | 未检出 |
ORVWTMC06013 | 128 | 0.4 | 4 | 20 | 1.88 | 43.91 |
ORVWTMC06014 | 131 | 1.9 | 4 | 20 | 2.31 | 72.25 |
ORVWTMC06015 | 114 | 0.8 | 4 | 室温 | 1.03 | 46.18 |
ORVWTMC06016 | 123 | 0.6 | 4 | 室温 | 1.52 | 56.72 |
ORVWTMC06017 | 128 | 0.7 | 4 | 室温 | 1.65 | 57.02 |
ORVWTMC06018 | 143 | 0.2 | 4 | 室温 | 1.79 | 未检出(n.d.) |
平均值 | 129 | 0.9 | 4 | 无意义(n.a.) | 1.3 | 55.4 |
最小值 | 113 | 0.2 | 4 | 20 | 0.5 | 42.5 |
最大值 | 159 | 2.0 | 4 | 25 | 2.6 | 72.3 |
Claims (22)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93089107P | 2007-05-18 | 2007-05-18 | |
US60/930,891 | 2007-05-18 | ||
PCT/US2008/006291 WO2008143977A1 (en) | 2007-05-18 | 2008-05-16 | Method for producing mature vwf from vwf pro-peptide |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101679496A true CN101679496A (zh) | 2010-03-24 |
CN101679496B CN101679496B (zh) | 2013-03-13 |
Family
ID=39666205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008800163745A Active CN101679496B (zh) | 2007-05-18 | 2008-05-16 | 用于由vwf前肽制备成熟vwf的方法 |
Country Status (17)
Country | Link |
---|---|
US (1) | US8058411B2 (zh) |
EP (1) | EP2152735B1 (zh) |
JP (2) | JP5053435B2 (zh) |
KR (1) | KR101156263B1 (zh) |
CN (1) | CN101679496B (zh) |
AU (1) | AU2008254522B2 (zh) |
BR (1) | BRPI0811649B8 (zh) |
CA (1) | CA2684151A1 (zh) |
DK (1) | DK2152735T3 (zh) |
ES (1) | ES2539284T3 (zh) |
HK (1) | HK1144577A1 (zh) |
HU (1) | HUE025257T2 (zh) |
MX (1) | MX2009012387A (zh) |
NZ (1) | NZ581582A (zh) |
PL (1) | PL2152735T3 (zh) |
PT (1) | PT2152735E (zh) |
WO (1) | WO2008143977A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112533940A (zh) * | 2018-03-21 | 2021-03-19 | 百深公司 | 通过色谱方法分离vwf和vwf前肽 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012082933A1 (en) * | 2010-12-15 | 2012-06-21 | Baxter International, Inc. | Eluate collection using conductivity gradient |
US20140276101A1 (en) * | 2013-03-14 | 2014-09-18 | Boston Scientific Scimed, Inc. | Medical device for detecting a target and related methods of use |
TWI666319B (zh) | 2014-08-12 | 2019-07-21 | 美商巴克斯歐塔公司 | 在分泌furin之哺乳動物表現系統中生產經完全加工且具功能性之因子X |
SG11201912962RA (en) | 2017-06-23 | 2020-01-30 | Baxalta Inc | Purification of factor viii subspecies |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT404838B (de) * | 1995-11-24 | 1999-03-25 | Immuno Ag | Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen |
AT407750B (de) | 1999-02-19 | 2001-05-25 | Immuno Ag | Verfahren zur herstellung einer vwf-präparation |
JP5022231B2 (ja) * | 2004-12-27 | 2012-09-12 | バクスター・インターナショナル・インコーポレイテッド | ポリマー−フォンビルブラント因子結合体 |
-
2008
- 2008-05-16 CN CN2008800163745A patent/CN101679496B/zh active Active
- 2008-05-16 NZ NZ581582A patent/NZ581582A/en unknown
- 2008-05-16 PT PT87545042T patent/PT2152735E/pt unknown
- 2008-05-16 AU AU2008254522A patent/AU2008254522B2/en active Active
- 2008-05-16 BR BRPI0811649A patent/BRPI0811649B8/pt active IP Right Grant
- 2008-05-16 EP EP08754504.2A patent/EP2152735B1/en active Active
- 2008-05-16 ES ES08754504.2T patent/ES2539284T3/es active Active
- 2008-05-16 PL PL08754504T patent/PL2152735T3/pl unknown
- 2008-05-16 JP JP2010508442A patent/JP5053435B2/ja active Active
- 2008-05-16 WO PCT/US2008/006291 patent/WO2008143977A1/en active Application Filing
- 2008-05-16 CA CA2684151A patent/CA2684151A1/en not_active Abandoned
- 2008-05-16 HU HUE08754504A patent/HUE025257T2/en unknown
- 2008-05-16 MX MX2009012387A patent/MX2009012387A/es active IP Right Grant
- 2008-05-16 US US12/152,762 patent/US8058411B2/en active Active
- 2008-05-16 DK DK08754504T patent/DK2152735T3/en active
- 2008-05-16 KR KR1020097026328A patent/KR101156263B1/ko active IP Right Grant
-
2010
- 2010-08-30 HK HK10108240.9A patent/HK1144577A1/xx unknown
-
2012
- 2012-07-25 JP JP2012164790A patent/JP2012210226A/ja not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112533940A (zh) * | 2018-03-21 | 2021-03-19 | 百深公司 | 通过色谱方法分离vwf和vwf前肽 |
Also Published As
Publication number | Publication date |
---|---|
CN101679496B (zh) | 2013-03-13 |
AU2008254522A1 (en) | 2008-11-27 |
JP2012210226A (ja) | 2012-11-01 |
BRPI0811649B1 (pt) | 2020-11-17 |
DK2152735T3 (en) | 2015-04-20 |
PL2152735T3 (pl) | 2015-08-31 |
KR20100028042A (ko) | 2010-03-11 |
AU2008254522A2 (en) | 2010-02-18 |
US20090029918A1 (en) | 2009-01-29 |
NZ581582A (en) | 2012-02-24 |
PT2152735E (pt) | 2015-07-21 |
US8058411B2 (en) | 2011-11-15 |
BRPI0811649B8 (pt) | 2021-05-25 |
CA2684151A1 (en) | 2008-11-27 |
HK1144577A1 (en) | 2011-02-25 |
AU2008254522B2 (en) | 2012-07-12 |
ES2539284T3 (es) | 2015-06-29 |
MX2009012387A (es) | 2010-02-10 |
WO2008143977A1 (en) | 2008-11-27 |
JP5053435B2 (ja) | 2012-10-17 |
KR101156263B1 (ko) | 2012-06-13 |
EP2152735B1 (en) | 2015-03-18 |
EP2152735A1 (en) | 2010-02-17 |
JP2010527588A (ja) | 2010-08-19 |
HUE025257T2 (en) | 2016-03-29 |
BRPI0811649A2 (pt) | 2014-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104981476B (zh) | 一种纯化治疗性蛋白质的方法 | |
CN101679496B (zh) | 用于由vwf前肽制备成熟vwf的方法 | |
US11149263B2 (en) | Method for purifying and quantifying thrombin and its degradation polypeptides | |
RU2544860C2 (ru) | Очистка полипептидов | |
KR101660533B1 (ko) | 인간 푸린의 분취 정제 방법 | |
CN102925422B (zh) | 尖吻蝮蛇血凝酶-b | |
JP2010527588A5 (zh) | ||
CN111849945A (zh) | 人凝血因子VIIa的纯化方法 | |
CN109485716B (zh) | 一种经修饰的生长分化因子及其制备方法与应用 | |
US10889630B2 (en) | Method of separating Factor VIII from blood products | |
CZ211299A3 (cs) | Derivát von Willebrandova faktoru, zařízení tento derivát obsahující a způsob isolace proteinů | |
CN103814137A (zh) | 处理凝血因子的方法 | |
Loh et al. | Adrenocorticotropic Hormone, β-Lipotropin, and Endorphin-Related Peptides in Health and Disease | |
WO2016207328A1 (en) | PROCESS FOR THE PURIFICATION OF γ-CARBOXYLATED POLYPEPTIDES | |
Takenaka et al. | Hb Izu (Macaca) β 83 (EF 7) Gly→ Cys: The major hemoglobin of the Japanese monkey (Macaca fuscata) in a troop at Shimokita, the northernmost limit of its habitat | |
JP2020127435A (ja) | トロンビン及びその分解ポリペプチドの精製及び定量化方法 | |
AU2012216707A1 (en) | Method for Producing Mature VWF From VWF Pro-peptide | |
JPH01190700A (ja) | 新規ペプチド | |
UA55005A (uk) | Спосіб виділення високоочищеного стандарту тромбіну людини |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1144577 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1144577 Country of ref document: HK |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160706 Address after: Aupu, Switzerland Patentee after: Hundred deep limited liability company Patentee after: Hundred deep company Address before: Illinois Patentee before: Baxter International Inc. Patentee before: Bakst Helth Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20210721 Address after: Osaka Patentee after: TAKEDA PHARMACEUTICAL Co.,Ltd. Address before: Aupu, Switzerland Patentee before: BAXALTA GmbH Patentee before: Baishen Co. |
|
TR01 | Transfer of patent right |